|
KMID : 0882420110810020190
|
|
Korean Journal of Medicine
2011 Volume.81 No. 2 p.190 ~ p.192
|
|
|
Endoscopic Sphincterotomy and Aspirin
|
|
Lee Jong-Kyun
|
|
|
Abstract
|
|
|
|
Antiplatelet drugs are associated with gastro-intestinal bleedings. Aspirin is one of most popular medicines for cardiovascular diseases. Endoscopic sphincterotomy (EST) has a high procedural risk of bleeding. However, there has been no evidence-based study about taking aspirin before and after EST. There are controversies in the guidelines from American Society for Gastrointestinal Endoscopy, British Society of Gastroenterology, and Japan Gastroenterological Endoscopy Society. Continuous intake of aspirin before EST is recommended in Western guidelines. To the contrary, 3 to 7 days cessation of aspirin before EST is needed according to Japan guidelines. Until a well-organized study make definite evidence, personalized approach is prudent to decide to stop or continue to take aspirin before and after EST.
|
|
|
KEYWORD
|
|
|
Aspirin, Endoscopic sphincterotomy, Bleeding
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|